These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4182111)

  • 21. [Changes in the synovial fluid following intra-articular injections of Proresid].
    Vojtísek O; Freund U; Greiling H
    Fysiatr Revmatol Vestn; 1969 Dec; 47(6):275-80. PubMed ID: 4188551
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D; Krieg R; Sauer D
    Strahlentherapie; 1969 Oct; 138(4):423-8. PubMed ID: 5352491
    [No Abstract]   [Full Text] [Related]  

  • 23. [Apropos of a case of carcinoma of the ovary].
    Clerc JP
    Gynaecologia; 1968; 165(2):77-8. PubMed ID: 5703823
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the treatment of malignant tumors with podophyllotoxin derivatives].
    Goldschmidt F; Busch W
    Arch Ohren Nasen Kehlkopfheilkd; 1965; 185(2):815-20. PubMed ID: 5881127
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant cancer chemotherapy. Development of a dosage schedule for the adjuvant cancer chemotherapy in surgical cases.
    Larsen V; Brockner J; Storm O
    Acta Chir Scand Suppl; 1965; 343():202-8. PubMed ID: 4158083
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G].
    Tomov V; Popov G; Stoianov E
    Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effects of podophyllin derivatives on malignant neoplasms].
    Diefenthaeler E; Herter NT
    Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action mechanism of cytostatic podophyllum derivates].
    Pohl J; Paeschke KD
    Krebsforsch Krebsbekampf; 1967; 6():130-3. PubMed ID: 6027109
    [No Abstract]   [Full Text] [Related]  

  • 30. [Observations on the treatment of lung cancer with a podophyllum derivative (SP-1)].
    Tansini G; Corti M; Gandini D; Zacco R
    G Ital Chemioter; 1965; 12(1):46-66. PubMed ID: 5881986
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic treatment of genital carcinoma].
    Limburg H
    Zentralbl Gynakol; 1969 Sep; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract]   [Full Text] [Related]  

  • 32. SPI and SPG in the treatment of advanced malignant lesions.
    Grewal TS; Samual KC; Sachdev DL; Rastogi DC
    Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental bases and clinical aspects of the use of 2 antimitotic derivatives of podophyllum].
    Fanchamps A
    J Med (Oporto); 1965 Nov; 58(191):673-92. PubMed ID: 5215285
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
    Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
    Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
    Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
    Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antimitotic effect of podophyllin derivatives on genital cancers].
    Stamm O
    Bull Soc R Belge Gynecol Obstet; 1965; 35(4):287-90. PubMed ID: 5856818
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of skin carcinoma with podophyllum derivatives.
    Bettley FR
    Br J Dermatol; 1971 Jan; 84(1):74-82. PubMed ID: 5573186
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the problem of the conservative treatment of gastric ulcer collosum].
    Norski T; Slończewski B; Bem Z
    Pol Tyg Lek; 1969 Jun; 24(23):891-3. PubMed ID: 5805042
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience in the therapeutic use of podophyllin in some dermatoses].
    Popov IS; Chepyzhenko VV
    Vrach Delo; 1966 Jan; 1():150-1. PubMed ID: 5974047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.